La lecture à portée de main
Découvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDécouvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDescription
Informations
Publié par | frost-sullivan |
Publié le | 10 décembre 2013 |
Nombre de lectures | 9 |
Langue | English |
Extrait
PR Newswire
LONDON, Dec. 10, 2013
- Microlife's clever brand positioning and positive feedback from the validating organizations help broaden the company's market presence
Based on its recent research on the blood pressure monitoring market, Frost & Sullivan presents Microlife Corporation (Microlife) with the 2013 European Frost & Sullivan Award for Competitive Strategy Innovation & Leadership. Microlife has strategically invested in R&D to address the unmet needs of a large patient base for the diagnosis of atrial fibrillation. It recently launched Watch BP Home A, an automated oscillometric blood pressure monitor equipped with an accurate atrial fibrillation detection system. The device is used at the initial level of screening for cardiovascular disorders such as hypertension and atrial fibrillation.